healthcare
Screening and diagnostic testing for cancer and additional predictive testing for treatment optimisation for clinicians and their patients.
Both gynae and non-gynae liquid based cytology services are available.
A range of pathology services for NHS and private healthcare organisations under the PathLore™ brand.
Committed to bringing you the best health care within central London.
Improves the predictability of efficacy for drugs which target EGFR inhibition to treat certain cancers such as colon cancer and small cell lung cancer.
Information and diagnostic and prognostic tests available for cancer patients and clinicians.
Leading the way to individualised breast cancer treatment by providing valuable, patient-specific information used to assist physicians in optimising treatment plans.